Enzyme selectivity of new cyclooxygenase-2/5 lipoxygenase inhibitors using molecular modeling approach
- PMID: 10983419
Enzyme selectivity of new cyclooxygenase-2/5 lipoxygenase inhibitors using molecular modeling approach
Abstract
We have studied the conformational flexibility of three 5-keto-substituted 7-tert-butyl-2,3-dihydro-3,3-dimethylbenzofurans (DHDMBFs) which show dual cyclooxygenase (COX) and 5-lipoxygenase (LOX) inhibition and are potential candidates as antiinflammatory agents and analgesics. The conformations were studied by systematic search, molecular mechanics (MM) and simulated annealing molecular dynamics (SAMD) techniques. We also studied several structure based parameters and distribution of molecular electrostatic potential (MEP) around these molecules. All the three compounds were docked in the active cavity of cyclooxygenase-2 (COX-2) using graphical and energy grid search techniques. The complex geometries were optimized by MM. The results on conformational flexibility, inter-atomic distances and angles, MEP distribution and points of contacts with peptide side chains in active cavity have been used to understand the mechanistic cause of differential action of these molecules.
Similar articles
-
New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.J Med Chem. 1998 Aug 27;41(18):3515-29. doi: 10.1021/jm9802416. J Med Chem. 1998. PMID: 9719605
-
Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.Farmaco. 2005 Apr;60(4):327-32. doi: 10.1016/j.farmac.2004.12.009. Farmaco. 2005. PMID: 15848208
-
Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.Bioorg Med Chem. 2006 May 15;14(10):3428-37. doi: 10.1016/j.bmc.2005.12.062. Epub 2006 Feb 2. Bioorg Med Chem. 2006. PMID: 16458008
-
Designing selective COX-2 inhibitors: molecular modeling approaches.Curr Opin Drug Discov Devel. 2002 Jul;5(4):550-61. Curr Opin Drug Discov Devel. 2002. PMID: 12197313 Review.
-
Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs.Eur J Med Chem. 2003 Jul-Aug;38(7-8):645-59. doi: 10.1016/s0223-5234(03)00115-6. Eur J Med Chem. 2003. PMID: 12932896 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials